TORONTO, Feb. 16 /CNW/ - Microbix Biosystems Inc. (MBX:TSX), a biotechnology company focused on virology and biological technologies, improved its cash flow by $2 million in the first quarter of fiscal 2010, moving from a negative cash flow of $2.4 million in the first quarter of fiscal 2009 to a negative $467,388 in the most recent quarter.
